http://orcid.org/0000-0002-9381-4892
References
- Siriwachirachai T, Piriyasupong T. Effect of dydrogesterone on treatment of threatened miscarriage: A systematic review and meta-analyses. Thai J Obstet Gynaecol. 2011;19(3):97–104.
- Ball RH, Ade CM, Schoenborn JA, Crane JP. The clinical significance of ultrasonographically detected subchorionic haemorrhages. Am J Obstetrics Gynecol. 1996;174(3):996–1002. doi:10.1016/S0002-9378(96)70339-3.
- Aksoy H, Aksoy U, Karadag OI, Hacımusalar Y, Acmaz G, Aykut G, et al. Effect of threatened miscarriage on maternal mood: A prospective controlled chort study. Turkiye Klinikleri J Gynecol Obst. 2015;25(2):92–8. doi:10.5336/gynobstet.2014-42689.
- de la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod. 2002;17(6):1649–56. doi:10.1093/humrep/17.6.1649. PMID:12042293
- Knöfler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol. 2010;54(2–3):269–80. doi:10.1387/ijdb.082769mk. PMID:19876833
- Phipps MG, Hogan JW, Peipert JF, Lambert-Messerlian GM, Canick JA, Seifer DB. Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol. 2000;95(2):227–31. PMID:10674584
- Hanita O, Hanisah AH. Potential use of single measurement of serum progesterone in detecting early pregnancy failure. Malays J Pathol. 2012;34(1):41–6. PMID:22870597
- Jeschke U, Hutter S, Heublein S, Vrekoussis T, Andergassen U, Unverdorben L et al. Expression and function of galectins in the endometrium and at the human feto-maternal interface. Placenta. 2013;34(10):863–72. doi:10.1016/j.placenta.2013.07.005. PMID:23911101
- Von Wolff M, Wang X, Gabius HJ, Strowitzki T. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol Hum Reprod. 2005;11(3):189–94. doi:10.1093/molehr/gah144. PMID:15681515
- Menkhorst EM, Gamage T, Cuman C, Kaitu'u-Lino TJ, Tong S, Dimitriadis E. Galectin-7 acts as an adhesion molecule during implantation and increased expression is associated with miscarriage. Placenta. 2014;35(3):195–201. doi:10.1016/j.placenta.2014.01.004. PMID:24522232
- Schulz H, Schmoeckel E, Kuhn C, Hofmann S, Mayr D, Mahner S et al. Galectins−1, −3, and −7 are prognostic markers for survival of ovarian cancer patients. Int J Mol Sci. 2017;18(6):1230. doi:10.3390/ijms18061230.
- Kaur M, Kaur T, Kamboj SS, Singh J. Roles of galectin-7 in cancer. Asian Pac J Cancer Prev. 2016;17(2):455–61. doi:10.7314/APJCP.2016.17.2.455. PMID:26925627
- Than NG, Romero R, Kim CJ, McGowen MR, Papp Z, Wildman DE. Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends Endocrinol Metab. 2012;23(1):23–31. doi:10.1016/j.tem.2011.09.003. PMID:22036528
- Unverdorben L, Haufe T, Santoso L, Hofmann S, Jeschke U, Hutter S. Prototype and chimera-type galectins in placentas with spontaneous and recurrent miscarriages. Int J Mol Sci. 2016;17(5):644. doi:10.3390/ijms17050644.
- Tirado-Gonzalez I, Freitag N, Barrientos G, Shaikly V, Nagaeva O, Strand M et al. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy. Mol Hum Reprod. 2013;19(1):43–53. doi:10.1093/molehr/gas043. PMID:23002109
- Menkhorst E, Koga K, Van Sinderen M, Dimitriadis E. Galectin-7 serum levels are altered prior to the onset of pre-eclampsia. Placenta. 2014;35(4):281–5. doi:10.1016/j.placenta.2014.01.009.
- Cowans NJ, Spencer K, Meiri H. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenat Diagn. 2008;28(2):121. doi:10.1002/pd.1921.